Literature DB >> 24166462

Efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in chronic hemodialysis patients.

Motoharu Hayashi1, Shinji Kaneko, Masayuki Shimano, Taiki Ohashi, Ryuji Kubota, Kyosuke Takeshita, Masanori Shinoda, Yasuya Inden, Hitoshi Kanayama, Toyoaki Murohara.   

Abstract

BACKGROUND: Radiofrequency catheter ablation (RFCA) is increasingly performed for the treatment of atrial fibrillation (AF), but it is problematic because the use of anti-arrhythmic agents is largely restricted in patients undergoing hemodialysis (HD) therapy. However, little is known about the long-term clinical outcomes of AF after RFCA in HD patients.
METHODS: Between 2002 and 2008, 16 HD patients (age: 63.8 ± 7.4 years, 75.0% men) underwent RFCA for AF at the Toyota Kosei Hospital. We investigated the long-term results and mortality of RFCA for AF in HD patients and compared them with those of 111 non-HD patients (age: 58.6 ± 10.0 years, 78.3% male) who received the same procedures.
RESULTS: During the follow-up (64.3 ± 25.4 months in HD patients, 70.5 ± 20.2 months in non-HD patients) after the initial RFCA procedure, sinus rhythm was restored in 4 HD patients (25%) and in 45 non-HD patients (40.5%). Multiple procedures were performed in 12 HD patients and in 57 non-HD patients. After the final procedure, 13 HD patients (81.3%) and 92 non-HD patients (82.9%) were free of atrial arrhythmia and symptoms. Of importance, Kaplan-Meier analysis did not demonstrate any significant differences in the atrial arrhythmia-free rate after the last procedure between HD patients and the control group matched after propensity-score analysis despite higher all-cause mortality in HD patients than in non-HD patients.
CONCLUSIONS: During 5-years of follow-up, the use of multiple RFCA procedures for AF in patients undergoing HD was favorable, whereas the use of a single procedure was disappointing. Multiple RFCA procedures can be an efficient approach to the treatment of AF in HD patients.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; hemodialysis

Mesh:

Substances:

Year:  2013        PMID: 24166462     DOI: 10.1093/ndt/gft233

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

1.  Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Authors:  Giuseppe Boriani; Irina Savelieva; Gheorghe-Andrei Dan; Jean Claude Deharo; Charles Ferro; Carsten W Israel; Deirdre A Lane; Gaetano La Manna; Joseph Morton; Angel Moya Mitjans; Marc A Vos; Mintu P Turakhia; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-24       Impact factor: 5.214

2.  Improvement in Quality of Life via Catheter Ablation for Atrial Fibrillation in Patients Undergoing Hemodialysis Therapy.

Authors:  Masato Hachisuka; Hiroshi Hayashi; Yu-Ki Iwasaki; Nobuaki Ito; Toshiki Arai; Serina Kobayashi; Rei Mimuro; Yuhi Fujimoto; Eiichiro Oka; Kanako Hagiwara; Ippei Tsuboi; Hiroshige Murata; Teppei Yamamoto; Michio Ogano; Kenji Yodogawa; Meiso Hayashi; Wataru Shimizu
Journal:  CJC Open       Date:  2022-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.